(KWWL) -- On Friday, May 7th, The World Health Organization ('WHO') gave authorization for emergency use of a COVID-19 vaccine manufactured by China called, Sinopharm.
Sinopharm was developed by the Beijing Institute of Biological Products.
It is the first vaccine that the WHO is backing that has been developed by a non-western country.
It joins a portfolio along with Pfizer, Astrazeneca, Moderna, and Johnson & Johnson.
While it's efficacy rate is in question, third world countries in Africa, Latin America, and Asia have approved Chinese shots for emergency use, and millions have already received the shot.
In spite of uncertainties with Sinopharm's efficacy rate, WHO said it has validated the "safety, efficacy and quality" of the Sinopharm vaccine.
The Sinopharm vaccine is to be administered to those 18 and older, and in two doses.